A randomized controlled trial of cognitive behavioral therapy compared with diabetes education for diabetic peripheral neuropathic pain. (March 2022)

• Record Type: Journal Article
• Authors: Higgins, Diana M; Heapy, Alicia A; Buta, Eugenia; LaChappelle, Kathryn M; Serowik, Kristin L; Czlapinski, Rebecca; Kerns, Robert D
• Is Part Of: Journal of health psychology. Volume 27:Number 3(2022)
• Page Start: 649
• Page End: 662
• Publication Date: 2022-03
• Subjects: cognitive behavior therapy -- diabetes -- health behavior -- pain -- randomized controlled trial; Clinical health psychology -- Periodicals; 613.019
• DOI: 10.1177/1359105320962262
• Languages: English
• ISSNs: 1359-1053

Abstract

A randomized controlled trial compared cognitive behavioral therapy (CBT) and diabetes education (ED) as an adjunctive treatment for diabetic peripheral neuropathic pain (DPNP). We examined change from baseline to 12- and 36-week follow-up in overall pain intensity (NRS), neuropathic pain intensity/quality, pain interference, and mental health functioning, among others. Although CBT participants demonstrated improvement in pain intensity NRS, there were no between-condition differences at either follow-up. CBT reduced neuropathic pain intensity at 12-weeks more than ED. At 36-weeks, CBT was superior to ED for improving pain interference and mental health functioning. Results provide evidence of benefit of CBT for DPNP. ClinicalTrials.gov Identifier : NCT00830011